SCHEMBL3342386

SCHEMBL3342386

Cc1ccc2c([N+](=O)[O-])cc[n+]([O-])c2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.49
CYP3A4 P08684 1/20 0.49
MAPT P10636 4/20 0.45
NPSR1 Q6W5P4 2/20 0.45
KDM4E B2RXH2 1/20 0.45
NPC1 O15118 1/20 0.45
S1PR4 O95977 1/20 0.45
S1PR1 P21453 1/20 0.45
HTT P42858 1/20 0.45
RAB9A P51151 1/20 0.45
MITF O75030 2/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
GPR35 Q9HC97 1/20 0.37
ALDH1A1 P00352 1/20 0.36
ACHE P22303 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3341802 0.87 TSHR (0.49) TSHRCYP3A4MAPTNPSR1KDM4E
4-Nitroquinoline-1-Oxide SCHEMBL105454 0.76 MAPT (0.56) TSHRCYP3A4MAPTNPSR1KDM4E
4-Nitroquinoline-1-Oxide SCHEMBL29367999 0.76 MAPT (0.56) TSHRCYP3A4MAPTNPSR1KDM4E
4-Nitroquinoline-1-Oxide SCHEMBL21114410 0.76 MAPT (0.56) TSHRCYP3A4MAPTNPSR1KDM4E
4-Nitroquinoline-1-Oxide SCHEMBL140249 0.73 MAPT (0.51) TSHRCYP3A4MAPTNPSR1KDM4E
SCHEMBL5803068 0.71 MAPT (0.43) MAPTNPSR1KDM4ENPC1S1PR4
SCHEMBL1561998 0.69 TSHR (0.60) TSHRCYP3A4MAPTNPSR1MITF
SCHEMBL2511534 0.68 TDP1 (0.52) TSHRCYP3A4MAPTNPSR1KDM4E
SCHEMBL29440728 0.68 TDP1 (0.52) TSHRCYP3A4MAPTNPSR1KDM4E
SCHEMBL539611 0.68 TDP1 (0.52) TSHRCYP3A4MAPTNPSR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100162416-A1 Multi-stage stem cell carcinogenesis STEMLIFELINE, INC. (US) 2010-06-24 US disclosed
WO-2010037134-A2 MULTI-STAGE STEM CELL CARCINOGENESIS STEMLIFELINE, INC. (US) 2010-04-01 WO disclosed